How brain function changes after brain stimulation in depression treated with ECT or MST
Official title: Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy
Run by The Second Hospital of Anhui Medical University · NCT07533773 · Data updated 2026-11-12
This study tests whether electroconvulsive therapy or magnetic seizure therapy, paired with a quick brain scan (fNIRS), can reveal brain function changes in people with major depressive disorder.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | The Second Hospital of Anhui Medical University Academic / other |
| Locations | 1 site (Hefei, Anhui) |
| Status | Recruiting |
| Started | April 30, 2026 |
| Main results expected | April 30, 2029 |
| Study ends | April 30, 2029 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07533773 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults diagnosed with a current major depressive episode who are candidates for ECT or MST and can complete fNIRS assessments.
✕Probably not a fit
Individuals not showing measurable brain changes with fNIRS or who do not respond to ECT/MST may not experience detectable benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study uses resting-state and task-based functional near-infrared spectroscopy to observe brain hemodynamics before and after treatment with electroconvulsive therapy or magnetic seizure therapy in adults with major depressive disorder. It aims to compare how these two neuromodulation approaches affect frontotemporal brain function and related cognitive processes. The study emphasizes the potential of a simple, noninvasive assessment method to complement cognitive testing and understand treatment-related brain changes. Eligible participants have a current depressive episode, adequate education, and consent to participate, with exclusions for certain co-morbid conditions and recent ECT/MST exposure. The study is led by The Second Hospital of Anhui Medical University in Hefei, China.
Why it matters
Potential benefit: Finding brain-function changes linked to ECT or MST could help tailor treatments and monitoring for depression.
How similar studies have gone: Prior research using neuromodulation and neuroimaging has shown brain-function changes, but direct comparisons between ECT and MST with fNIRS are limited and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A depressive episode diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), confirmed by two psychiatrists; * Meets the treatment criteria for ECT or MST; * At least 5 years of education, with no significant hearing or visual impairments; * Voluntary participation in this study, with a signed written informed consent form, and willingness to cooperate with the collection of general demographic information, neuropsychological testing, and fNIRS resting-state and task-based data acquisition. Exclusion Criteria: * Co-occurring mental disorders (such as substance use disorders or schizoaffective disorder); * Severe physical illness; * History of neurological disorders (such as traumatic brain injury or dementia); * Low educational attainment; * Receipt of ECT or MST treatment within the past six months.
Where it's running
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China Recruiting
Study contacts
- Study coordinator: Yanghua Tian
- Email: tianyh@ahmu.edu.cn
- Phone: +86-13955188448
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Temporally Interfering Electrical Stimulation for Major Depressive Disorder
This study tests whether noninvasive temporally interfering electrical stimulation can help people with major depressive disorder.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
ALKS 7290 added to antidepressants for adults with major depression
This study tests whether ALKS 7290, taken with current antidepressants, helps adults with major depressive disorder.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
-
EEG-Guided TMS for Adults With Depression
This study tests whether delivering intermittent theta burst stimulation (iTBS) timed to brain waves using EEG can improve treatment for adults with major depressive disorder who have not responded to usual antidepressants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.